Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) to present at 42nd Annual J.P. Morgan Healthcare Conference

HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 42^nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets, ARCALYST, KPL-404, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.

ARCALYST^® is a registered trademark of Regeneron Pharmaceuticals, Inc.

Every Second Counts! ^®

Kiniksa Investor and Media Contact
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com

When will Kiniksa Pharmaceuticals, Ltd. present at the 42nd Annual J.P. Morgan Healthcare Conference?

Kiniksa Pharmaceuticals, Ltd. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).

Where can I watch the live webcast of Kiniksa Pharmaceuticals, Ltd.'s presentation?

The live webcast of Kiniksa Pharmaceuticals, Ltd.'s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available on Kiniksa Pharmaceuticals, Ltd.'s website within approximately 48 hours after the event.